Common Contracts

2 similar Sales Agreement contracts by Applied Therapeutics, Inc., Stereotaxis, Inc.

Applied Therapeutics, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • August 29th, 2025 • Applied Therapeutics, Inc. • Pharmaceutical preparations • New York

Applied Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

STEREOTAXIS, INC. Common Stock ($0.001 par value per share) Sales Agreement
Sales Agreement • August 29th, 2025 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus • New York

Stereotaxis, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows: